ArticleBMC pulmonary medicine2025
Chylous pericardial tamponade following postoperative chylothorax after right upper lobectomy: a case report of a rare entity.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative chylothorax is a known but uncommon complication of lung cancer surgery. Progression to chylous pericardial effusion and tamponade is exceedingly rare but can be rapidly fatal if not recognized and treated promptly. CASE PRESENTATION: A 72-year-old man underwent right upper lobectomy with bronchus-sleeve resection and systematic mediastinal lymphadenectomy for squamous cell carcinoma. In the early postoperative course, a high-output chylothorax was diagnosed. On postoperative day (POD) 4, he developed paroxysmal atrial fibrillation with hemodynamic instability, requiring brief ICU admission for cardioversion. On POD 6, he suddenly deteriorated with obstructive shock with hypotension, tachycardia, pronounced mottled skin extending to the abdomen, and decreased level of consciousness. Bedside transthoracic echocardiography revealed a large pericardial effusion with tamponade physiology. Emergency pericardiocentesis drained 800 mL of milky fluid with high triglycerides, consistent with chylopericardium, and resulted in immediate hemodynamic stabilization. Interventional radiology attempted bilateral intranodal lymphangiography and thoracic duct embolization via lymphatic, venous and percutaneous routes; despite partial opacification of lymphatic channels, catheterization and embolization was unsuccessful. On POD 7, surgical re-thoracotomy with thoracic duct ligation above the diaphragm and lymphatic fistula closure was performed. The pericardial drain was removed on POD 8, echocardiography confirmed no recurrence, and the patient recovered uneventfully. DISCUSSION: Chylous pericardial tamponade is extremely rare but life-threatening. Previous reports describe a spectrum from successful conservative therapy to surgical interventions, with at least one fatal outcome despite drainage (Fukumoto et al. Surg Case Rep. 11:87; 2025). Our case highlights three points: (1) transthoracic echocardiography is indispensable for rapid diagnosis of tamponade in unstable postoperative patients; (2) interventional radiology, although attempted, was unsuccessful and should not delay definitive treatment; (3) surgical thoracic duct ligation and pericardial drainage remain the most reliable interventions.
conclusionChylous pericardial tamponade should be considered in patients with postoperative chylothorax who deteriorate hemodynamically. Rapid echocardiography, emergency pericardial drainage, and timely surgical management are key to survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.